Advanced Search Results For "Brzdęk, Michał"
Your filters
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
Publication Type: Academic Journal
Source(s): Journal of Clinical Medicine, Vol 12, Iss 2371, p 2371 (2023)
Abstract: Continuous evaluation of real-world treatment effectiveness of COVID-19 medicines is required due to the ongoing evolution of SARS-CoV-2 and the possible emergence of resistance. Therefore, this study aimed to analyze, in a retrospective manner, the ou...
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
Publication Type: Academic Journal
Source(s): Viruses, Vol 15, Iss 677, p 677 (2023)
Abstract: Direct-acting antivirals (DAA) regimens have provided hope for eliminating hepatitis C virus (HCV) infection. Patients following ineffective therapy with DAA, especially those previously treated with inhibitors of non-structural protein 5A (NS5A), rema...
Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the interferon -free era.
Publication Type: Academic Journal
Source(s): Polish Archives of Internal Medicine. Sep2022, Vol. 132 Issue 9, p1-11. 11p.
COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
Publication Type: Academic Journal
Source(s): Vaccines, Vol 10, Iss 1223, p 1223 (2022)
Abstract: In the light of the lack of authorized COVID-19 vaccines adapted to the Omicron variant lineage, the administration of the first and second booster dose is recommended. It remains important to monitor the efficacy of such an approach in order to inform...
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.
Publication Type: Academic Journal
Source(s): Journal of Clinical Medicine; Mar2023, Vol. 12 Issue 6, p2371, 16p
Abstract: Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or e...
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.
Publication Type: Academic Journal
Source(s): Viruses (1999-4915); Mar2023, Vol. 15 Issue 3, p677, 15p
Abstract: Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email arti...
Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
Publication Type: Academic Journal
Source(s): Vaccines, Vol 10, Iss 557, p 557 (2022)
Abstract: The emergence of a highly transmissible and a more pathogenic B.1.617.2 (delta) variant of SARS-CoV-2 has brought concern over COVID-19 vaccine efficacy and the increased risk of severe breakthrough infections. The objective of this study was to assess...
Does Hospitalization Change the Perception of COVID-19 Vaccines among Unvaccinated Patients?
Publication Type: Academic Journal
Source(s): Vaccines, Vol 10, Iss 476, p 476 (2022)
Abstract: The COVID-19 vaccination has been the subject of unprecedented misinformation, false news, and public concerns. This study presents a unique analysis comprising persons who were not vaccinated and became ill. It investigates reasons for not vaccinating...
Genotype 4 hepatitis C virus-a review of a diverse genotype.
Publication Type: Academic Journal
Source(s): Advances in Medical Sciences (Elsevier Inc.). Mar2023, Vol. 68 Issue 1, p54-59. 6p.
Abstract: Hepatitis C virus (HCV) infection remains a major health problem and one of the leading causes of chronic liver disease worldwide. The purpose of this paper was to summarize knowledge about the epidemiology of HCV genotype (GT) 4 infection, similaritie...
Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
Publication Type: Academic Journal
Source(s): Viruses, Vol 14, Iss 96, p 96 (2022)
Abstract: Difficult-to-treat populations with chronic hepatitis C (CHC), in the era of interferon treatment, included patients with liver cirrhosis, kidney impairment, treatment-experienced individuals, and those coinfected with the human immunodeficiency virus....